Recognized in Best Lawyers since 2027 
Emma acts for clients in health, life sciences, biotechnology, technology, agriculture, infrastructure, retail and manufacturing sectors. Her practice includes cross-border transactions with an Asia focus, particularly involving clients in Hong Kong, Singapore, the People's Republic of China and Indonesia.
Emma advises on equity and debt capital markets, mergers and acquisitions, private equity and corporate advisory. She provides clients with access to high-level skills in areas that are heavily regulated and highly technical, spanning the full transaction lifecycle from structuring through to execution and governance.
Her practice spans the full range of capital markets and M&A complexity in highly regulated sectors including life sciences and biotechnology.
Emma's combination of technical capital markets expertise with deep sector knowledge in health and life sciences, and her cross-border Asia-Pacific capability, positions her as a specialist in regulated sector transactions.
